News
Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial ...
As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...
This was the stock's third consecutive day of gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results